
Bionexo
São Paulo, Brazil · Founded 2000 · $82.5M raised
- Headquarters
- São Paulo
- Employees
- 501–1000
- Founded
- 2000
- Business Model
- B2B
- Website
- bionexo.com.br
- Total Funding
- $82.5M
- Last Round
- $82.5M Growth EquityOct 2021
- Rounds
- 3
About
Bionexo is a community made up of thousands of agents in the healthcare sector. Through its innovative web platforms, Bionexo integrates hundreds of hospitals with thousands of health care suppliers across the entire production chain, with a focus on developing sustainable businesses relationships, best results and encouraging transparency. In its 12 years of existence, Bionexo has become an industry leader in the healthcare sector in Brazil, Argentina, Colombia, Mexico and Spain.
Summary
Bionexo is a Data & Analytics company based in São Paulo, Brazil, founded in 2000. It has raised $82.5M in total across 3 rounds, most recently a $82.5M Growth Equity round in Oct 2021. Investors include Prisma Capital, Bain Capital Tech Opportunities and Insight Partners.
Tech & App Stack
7 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2021
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies

Databricks is the pioneer of the data lakehouse, a unified platform for data science, machine lea...

Quest Software (Nasdaq: QSFT) is a provider of application and information availability software ...
OneOncology empowers oncology practices with advanced tools and capabilities to help physicians d...
Palantir Technologies builds data integration and analytics platforms (Gotham and Foundry) for go...

Healthcare governance, risk, and compliance software provider helping organizations improve patie...

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...

